H.I.G. Capital Completes Sale of Soleo Health
- Editor
- Feb 3
- 1 min read
What's Happening: H.I.G. Capital, a global alternative investment firm with $67 billion in capital under management, has sold its portfolio company Soleo Health to funds managed by Court Square Capital and WindRose Health Investors. Soleo Health is a national provider of complex specialty pharmacy services and infusion therapy.
The Key Moves:
H.I.G. supported Soleo's expansion through de novo pharmacy and infusion suite openings.
The company introduced a differentiated therapy-specific clinical model under H.I.G.'s ownership.
Soleo diversified its payor, site-of-care, and therapy offerings during H.I.G.'s tenure.
By The Numbers :
H.I.G. Capital has $67 billion of capital under management.
Soleo Health operates 26 pharmacies and over 30 ambulatory infusion suites across the United States.
The company serves patients across all 50 states through its extensive pharmacy licensure and specialized nursing network.
Key Quotes:
Drew Walk, President and CEO of Soleo: "H.I.G. has been an exceptional partner to Soleo and instrumental in helping us build the Company into the market leader we are today."
Scott Zhu, Managing Director at H.I.G.: "Drew and the Soleo management team have done an outstanding job transforming Soleo from a regional infusion player into a national specialty care provider, with a variety of compelling growth opportunities."
*KQ3*
The Bottom Line: H.I.G. Capital's successful exit from Soleo Health demonstrates the firm's ability to transform and grow healthcare companies. The sale to Court Square Capital and WindRose Health Investors marks a significant milestone for Soleo, which has evolved into a national leader in specialty pharmacy and infusion services under H.I.G.'s ownership.
Comments